Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.
Márquez-Rodas I, Martín González M, Nagore E, Gómez-Fernández C, Avilés-Izquierdo JA, Maldonado-Seral C, Soriano V, Majem-Tarruella M, Palomar V, Maseda R, Martín-Carnicero A, Puertolas T, Godoy E, Cerezuela P, Ochoa de Olza M, Campos B, Perez-Ruiz E, Soria A, Gil-Arnaiz I, Gonzalez-Cao M, Galvez E, Arance A, Belon J, de la Cruz-Merino L, Martín-Algarra S; Spanish Multidisciplinary Group of Melanoma (GEM). Márquez-Rodas I, et al. Among authors: belon j. PLoS One. 2015 Apr 13;10(4):e0124239. doi: 10.1371/journal.pone.0124239. eCollection 2015. PLoS One. 2015. PMID: 25874698 Free PMC article.
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H. Hitt R, et al. Among authors: belon j. J Clin Oncol. 2005 Dec 1;23(34):8636-45. doi: 10.1200/JCO.2004.00.1990. Epub 2005 Nov 7. J Clin Oncol. 2005. PMID: 16275937 Clinical Trial.
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.).
Díaz-Rubio E, Jimeno J, Antón A, Aranda E, Sánchez J, Massuti B, Cruz-Hernández J, Carrato A, Martin M, Belón J, et al. Díaz-Rubio E, et al. Among authors: belon j. Am J Clin Oncol. 1992 Feb;15(1):56-60. doi: 10.1097/00000421-199202000-00011. Am J Clin Oncol. 1992. PMID: 1550080 Clinical Trial.
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Cervantes A, Villar-Grimalt A, Abad A, Antón-Torres A, Belón J, Dorta J, Tres A, Camps C, Fonseca E, Massutí B, et al. Cervantes A, et al. Among authors: belon j. Ann Oncol. 1993 Nov;4(9):753-7. doi: 10.1093/oxfordjournals.annonc.a058660. Ann Oncol. 1993. PMID: 8280656 Free article. Clinical Trial.
A multicenter randomized Phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma. PSAMOMA Cooperative Group, Spain.
Hidalgo M, Mendiola C, López-Vega JM, Castellano D, Mendez M, Batiste-Alenton E, López-Brea M, Belon J, Batista JN, Cortés-Funes H. Hidalgo M, et al. Among authors: belon j. Cancer. 1998 Aug 15;83(4):719-25. doi: 10.1002/(sici)1097-0142(19980815)83:4<719::aid-cncr13>3.0.co;2-v. Cancer. 1998. PMID: 9708936 Clinical Trial.
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society).
Villar-Grimalt A, Aranda E, Massutí B, Belón J, Antón A, Jimeno JM, Candel MT, García de Paredes ML, Colajori E. Villar-Grimalt A, et al. Among authors: belon j. Tumori. 1994 Apr 30;80(2):124-7. doi: 10.1177/030089169408000207. Tumori. 1994. PMID: 8016902 Clinical Trial.
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer.
Espinosa E, Morales S, Borrega P, Casas A, Madroñal C, Machengs I, Illarramendi JA, Lizón J, Moreno JA, Belón J, Janáriz J, de la Puente M, Checa T, Mel JR, González Barón M. Espinosa E, et al. Among authors: belon j. Cancer Chemother Pharmacol. 2004 Dec;54(6):546-52. doi: 10.1007/s00280-004-0830-1. Epub 2004 Aug 17. Cancer Chemother Pharmacol. 2004. PMID: 15316749 Clinical Trial.
71 results